Certican 0,5 mg tablete
| Name | Certican 0,5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-592546271 |
| Active Substance | everolimus |
| Composition | jedna tableta sadrži 0,5 mg everolimusa |
| Pharmaceutical Form | tableta |
| Manufacturer | Novartis Pharma GmbH, Nürnberg, Njemačka Novartis Farmacéutica S.A., Barcelona, Španjolska Sandoz S.R.L., Targu Mures, Rumunjska |
| Marketing Authorisation Holder | Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, Hrvatska |
| Marketing Authorisation Date | 22.09.2016 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/115 |
| Registration Number | 381-12-01/38-16-03 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L04AH02 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
